Category Archives: Post graduate

Ziprasidone (Geodon®)

Ziprasidone (US brand name Geodon® and generic) is a second-generation (“atypical”) antipsychotic. FDA-approved indications A. As an oral formulation 1. Schizophrenia 2. Acute treatment as monotherapy of manic or mixed episodes associated with bipolar I disorder 3. Maintenance treatment of bipolar I disorder as an adjunct to lithium or valproate B. As an intramuscular injection […]

Iloperidone (Fanapt®): Basic Information

Iloperidone (US brand name Fanapt®) is a second-generation (“atypical”) antipsychotic. FDA-approved indications Treatment of adults with schizophrenia Dosage Starting: 1 mg twice daily Target: 6–12 mg twice daily (achieved by dose increments of 1–2 mg twice daily) Maximum: 12 mg twice daily (24 mg/day) Please refer to Prescribing Information (see link below) for complete discussion […]

Cariprazine (Vraylar®)

Cariprazine (Vraylar®) is a second-generation (atypical) antipsychotic. Here is basic information about this medication. FDA-approved indications 1. Schizophrenia 2. Acute treatment of manic or mixed episodes associated with bipolar I disorder. Dosage Schizophrenia Starting: 1.5 mg/day Recommended: 1.5–6 mg/day Bipolar Mania Starting: 1.5 mg/day Recommended: 3–6 mg/day Please refer to Prescribing Information (see link below) for […]

Asenapine (Saphris®)

Asenapine (US brand name Saphris®) is a second-generation (“atypical”) antipsychotic. FDA-approved indications 1. Schizophrenia 2. Acute treatment of manic and mixed episodes associated with bipolar I disorder (monotherapy) 3. Acute treatment of manic and mixed episodes associated with bipolar I disorder (adjunctive to lithium or valproate) Dosage Schizophrenia – acute treatment in adults Starting: 5 […]

Aripiprazole (Abilify®)

Aripiprazole (US brand name Abilify® and generic Aripiprix, zolonda) is a second-or third generation (atypical) antipsychotic. FDA-approved indications A. Oral 1. Schizophrenia 2. Acute treatment of manic and mixed episodes associated with bipolar I disorder 3. Adjunctive treatment of major depressive disorder 4. Irritability associated with autistic disorder 5. Treatment of Tourette’s disorder B. Injectable […]

Haloperidol

Haloperidol (US brand name Haldol® and generic) is a first-generation (“typical”) antipsychotic. Here is basic information about this medication. Oral Haloperidol (Tablets, Oral concentrate) FDA-approved indications 1. Management of manifestations of psychotic disorders 2. Control of tics and vocal utterances of Tourette’s Disorder in children and adults 3. Treatment of severe behavior problems in children of combative, […]

mood dys-regulation disorder: Diagnosis and Management

Professor Dr. Heba El Shehawi,Professor of Child Psychiatry,,Institute of Psychiatry,Ain Shams University,Egypt. She is giving a full lecture about mood dysregulation disorders among children, diagnosis and management. Professor Heba has a full clinical experience in the field and she is running a daily child psychiatry clinic managing different disorder.

Evolution of the brain: Psychiatrist and Mind

Professor Ahmed Okasha, gives a full lecture about psychiatry, mind and the brain. Evolution of the human brain from psychiatric point of view. Lecture is mostly in arabic for everyone working in the field of psychiatry, psychology , medicine and anthropology as well. It is a global view , comparative , analyzing and critical thinking. […]

Rediscovering clozapine: Adverse effects develop—what should you do now?

Current Psychiatry 2016 August;15(8):40-46,48-49. Brianne M. Newman, MD Associate Professor of Psychiatry Department of Psychiatry Saint Louis University School of Medicine St. Louis, Missouri William J. Newman, MD Associate Professor of Psychiatry Department of Psychiatry Saint Louis University School of Medicine St. Louis, Missouri Member of the Editorial Board of Current Psychiatry   Clozapine is […]

O Psychiatrists Screen for abnormal blood glucose, diabetes!

USPSTF update: Screen all adults, ages 40 to 70 years, who are overweight or obese. Consider screening younger patients who have specific personal or family risk factors. J Fam Pract. 2016 July;65(7):481-483. Doug Campos-Outcalt, MD, MPA Medical Director, Mercy Care Plan, Phoenix, Ariz [email protected] In December 2015, the United States Preventive Services Task Force updated […]

New Brain Map Charts Fresh Territory

Megan Brooks July 21, 2016 A team of neuroscientists has charted the most complex and precise map of the human cerebral cortex to date, and it has revealed almost 100 new regions. These findings will provide a greater understanding, as well as advance the study, of brain disorders such as autism, schizophrenia, dementia, and epilepsy. […]